Celgene Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Celgene careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: December 12, 2018, 9:54 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: December 12, 2018, 9:54 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: December 12, 2018, 9:54 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: December 12, 2018, 9:53 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: December 12, 2018, 9:51 am

Viewing page 1 of 100|Next Page

  Newsfeed | Subscribe  

Marta Suazo has received the Sol J. Barer Scholarship in Life Sciences from Celgene, a global biopharmaceutical company headquartered in Summit, NJ. The scholarship is named for the co-founder of Celg...
Posted: December 11, 2018, 7:19 pm
Celgene (CELG) closed at $69.49 in the latest trading session, marking a +1.18% move from the prior day. This move outpaced the S&P 500's daily loss of 0.04%. Meanwhile, the Dow lost 0.22%, and ...
Posted: December 11, 2018, 3:45 pm
The last few years have been a difficult ride for investors in large-cap biotech Celgene ( CELG ). The stock is down 37% year-on-year and is testing five-year lows. Celgene is currently trading ...
Posted: December 11, 2018, 7:48 am
Celgene announces positive preliminary data from its study treating patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) using JCAR017.
Posted: December 6, 2018, 4:48 pm
A combination of Johnson & Johnson and Genmab’s Darzalex with Celgene’s Revlimid plus a chemotherapy produced results that doctors said would alter the face of care for elderly and frail multiple myel...
Posted: December 6, 2018, 11:43 am

Viewing page 1 of 3|Next Page